Publications by authors named "Lanlan Si"

Claim this Profile
H
Hepatitis B virus rtCYE/rtCYEI mutations may contribute limited tenofovir resistance: Analysis of a large sample of Chinese patients.
Lan-Lan Si, Zhen-Ping Fan, Wen-Hui Liu, Rong-Juan Chen, Xue-Yuan Chen

World J Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of TOMM34 on NF-κB activation-related hyperinflammation in severely ill patients with COVID-19 and influenza.
Qiwen Shi, Pengfei Zhang, Qingtao Hu, Tianxin Zhang, Ruixia Hou, Lanlan Si

EBioMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of hepatitis B virus selective apoptosis modulation by Chinese patent medicine Liuweiwuling Tablet.
Fei-Lin Ge, Yan Yang, Lan-Lan Si, Yuan-Hua Li, Meng-Zhen Cao

World J Gastroenterol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges.
Feilin Ge, Yan Yang, Zhaofang Bai, Lanlan Si, Xuemei Wang

Chin Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleos(t)ide analogues altered quasispecies composition of hepatitis B virus (HBV)-resistant mutations in serum HBV DNA and serum HBV RNA.
Hao Liao, He Zhang, Jinman Shao, Xiaoyong Li, Wei V Zheng, Lanlan Si

J Med Virol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients.
Hao Liao, Le Li, Wei V Zheng, Jun Zou, Guangxin Yu, Lanlan Si

Dis Markers· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) and Effectively Suppressed HBV Replication in Mouse Model.
Fei-Lin Ge, Lan-Lan Si, Yan Yang, Yuan-Hua Li, Zhong-Lin Lv

Front Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogs.
Yan Liu, Rongjuan Chen, Wenhui Liu, Lanlan Si, Le Li

Antiviral Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sK122R mutation of hepatitis B virus (HBV) is associated with occult HBV infection: Analysis of a large cohort of Chinese patients.
Jun Wang, Yan Liu, Hao Liao, Lujie Liu, Rongjuan Chen, Lanlan Si

J Clin Virol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations.
Bi-Xia Huang, Yan Liu, Zhen-Ping Fan, Lan-Lan Si, Rong-Juan Chen

World J Gastroenterol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus mutation pattern rtA181S+T184I+M204I may contribute to multidrug resistance in clinical practice: Analysis of a large cohort of Chinese patients.
Rongjuan Chen, Yan Liu, Dan Luo, Lanlan Si, Bixia Huang

Antiviral Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice.
Yan Liu, Yi Zhou, Xiaodong Li, Ming Niu, Rongjuan Chen, Lanlan Si

Emerg Microbes Infect· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
Yan Liu, Weiming Yao, Lanlan Si, Jun Hou, Jiabo Wang

Antiviral Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S-gene mutants isolated from individuals with occult HBV infection.
Kai Zhang, Yan Liu, Rongjuan Chen, Qi Li, Zhihui Xu, Lanlan Si

J Med Virol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs.
Yan Qiao, Shanshan Lu, Zhihui Xu, Xiaodong Li, Kai Zhang, Lanlan Si

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.
Jianhong Chen, Yan Liu, Jun Zhao, Zhihui Xu, Rongjuan Chen, Lanlan Si

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China.
Hao Liao, Yan Liu, Jianhong Chen, Weiping Ding, Xiaodong Li, Lanlan Si

Transfusion· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese.
Yuanfeng Li, Lanlan Si, Yun Zhai, Yanling Hu, Zhibin Hu

Nat Commun· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation.
Dong Ji, Yan Liu, Le Li, Zhihui Xu, Lan-Lan Si

J Clin Virol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients.
Dong Ji, Yan Liu, Lan-Lan Si, Le Li, Guo-Feng Chen

Clin Chim Acta· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
Zhihui Xu, Yan Liu, Teng Xu, Li Chen, Lanlan Si

J Clin Virol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis